Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs

  • Gallizioli, Mattia
  • Miró-Mur, Francesc
  • Otxoa-de-Amezaga, Amaia
  • Cugota, Roger
  • Salas-Perdomo, Angélica
  • Justicia, Carles
  • Brait, Vanessa H
  • Ruiz-Jaén, Francisca
  • Arbaizar-Rovirosa, Maria
  • Pedragosa, Jordi
  • Bonfill-Teixidor, Ester
  • Gelderblom, Mathias
  • Magnus, Tim
  • Cano, Eva
  • del Fresno, Carlos
  • Sancho, David
  • Planas, Anna M
Brain CD11c+ cells share features with microglia and dendritic cells (DCs). Sterile inflammation increases brain CD11c+ cells, but their phenotype, origin, and functions remain largely unknown. We report that, after cerebral ischemia, microglia attract DCs to the inflamed brain, and astroglia produce Flt3 ligand, supporting development and expansion of CD11c+ cells. CD11c+ cells in the inflamed brain are a complex population derived from proliferating microglia and infiltrating DCs, including a major subset of OX40L+ conventional cDC2, and also cDC1, plasmacytoid, and monocyte-derived DCs. Despite sharing certain morphological features and markers, CD11c+ microglia and DCs display differential expression of pattern recognition receptors and chemokine receptors. DCs excel CD11c- and CD11c+ microglia in the capacity to present antigen through MHCI and MHCII. Of note, cDC1s protect from brain injury after ischemia. We thus reveal aspects of the dynamics and functions of brain DCs in the regulation of inflammation and immunity.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

IL-23 (Interleukin-23)-producing conventional dendritic cells control the detrimental IL-17 (Interleukin-17) response in stroke

  • Gelderblom, Mathias
  • Gallizioli, Mattia
  • Ludewig, Peter
  • Thom, Vivien
  • Arunachalam, Priyadharshini
  • Rissiek, Björn
  • Bernreuther, Christian
  • Glatzel, Markus
  • Korn, Thomas
  • Arumugam, Thiruma Valavan
  • Sedlacik, Jan
  • Gerloff, Christian
  • Tolosa, Eva
  • Planas, Anna M.
  • Magnus, Tim
[Background and Purpose] Inflammatory mechanisms can exacerbate ischemic tissue damage and worsen clinical outcome in patients with stroke. Both αβ and γδ T cells are established mediators of tissue damage in stroke, and the role of dendritic cells (DCs) in inducing the early events of T cell activation and differentiation in stroke is not well understood., [Methods] In a murine model of experimental stroke, we defined the immune phenotype of infiltrating DC subsets based on flow cytometry of surface markers, the expression of ontogenetic markers, and cytokine levels. We used conditional DC depletion, bone marrow chimeric mice, and IL-23 (interleukin-23) receptor-deficient mice to further explore the functional role of DCs., [Results] We show that the ischemic brain was rapidly infiltrated by IRF4+/CD172a+ conventional type 2 DCs and that conventional type 2 DCs were the most abundant subset in comparison with all other DC subsets. Twenty-four hours after ischemia onset, conventional type 2 DCs became the major source of IL-23, promoting neutrophil infiltration by induction of IL-17 (interleukin-17) in γδ T cells. Functionally, the depletion of CD11c+ cells or the genetic disruption of the IL-23 signaling abrogated both IL-17 production in γδ T cells and neutrophil infiltration. Interruption of the IL-23/IL-17 cascade decreased infarct size and improved neurological outcome after stroke., [Conclusions] Our results suggest a central role for interferon regulatory factor 4-positive IL-23–producing conventional DCs in the IL-17–dependent secondary tissue damage in stroke., This work was supported by grants from the European Research Area Network/nEUROSurv (Dr Magnus) and the Hermann und Lilly Schilling-Foundation for Medical Research (Dr Magnus). M. Gallizioli was supported by the European Community (FP7-PEOPLE-2013-ITN-n°07962). Dr Korn was supported by the Deutsche Forschungsgemeinschaft (SFB 1054 and TR 128), by the European Research Council (CoG 647215 to Dr Korn), and by the German Ministry of Education and Research (Kompetenznetz Multiple Sklerose, T-BinNMO)., Peer reviewed